Amgen Financial Indicators Patterns

AMGN -- USA Stock  

USD 185.16  0.01  0.0054%

We suggest you to use Amgen fundamental analysis to see if markets are presently mispricing the company. In plain English you can use it to find out if Amgen is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found thirty-eight available fundamental indicators for Amgen which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Amgen fundamentals including its EBITDA, Cash Flow from Operations and the relationship between Price to Book and Total Debt . Given that Amgen has Price to Earning of 61.01 times, we suggest you validate Amgen prevailing market performance to make sure the company can sustain itself down the road.Use Amgen to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of Amgen to be traded at $194.42 in 30 days

Amgen Valuation Over Time

Enterprise Value

Amgen Company Summary

Amgen competes with Vertex Pharmaceuticals, Endo International, Abbott Laboratories, Allergan plc, and BIO RAD. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ. It employs 20800 people.

Amgen Price to Book vs Return On Asset

Amgen is number one stock in price to book category among related companies. It is rated second in return on asset category among related companies reporting about  1.11  of Return On Asset per Price to Book.

Amgen Systematic Risk

The output start index for this execution was six with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Amgen correlated with the market. If Beta is less than 0 Amgen generally moves in the opposite direction as compared to the market. If Amgen Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amgen is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amgen is generally in the same direction as the market. If Beta > 1 Amgen moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

Amgen Financial Distress Probability
28% 

Chance of Financial Distress

Amgen has less than 28 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Amgen Thematic Clasifications

Active Themes That Utilize Amgen
Robots And Drones IdeaRobots And DronesView
Macroaxis Index IdeaMacroaxis IndexView
Baby Boomer Prospects IdeaBaby Boomer ProspectsView
Giant Impact IdeaGiant ImpactView
Healthcare IdeaHealthcareView

Growth

Amgen Growth Changes

EPS Diluted Growth

EPS Growth

NCFO Growth

Opportunity Range

June 25, 2018 Opportunity Range
Check also Trending Equities. Please also try World Markets Correlation module to find global opportunities by holding instruments from different markets.